Evidence map›Paper›PMID 36850896›Full record

ArticleSensors (Basel, Switzerland)2023

Opal Actigraphy (Activity and Sleep) Measures Compared to ActiGraph: A Validation Study.

Vrutangkumar V Shah, Barbara H Brumbach, Sean Pearson, Paul Vasilyev, Edward King, Patricia Carlson-Kuhta, Martina Mancini, Fay B Horak, Kristen Sowalsky, James McNames and 1 more

Open access · goldFull text read
In one paragraph

Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Physical activity among pregnant inpatients and outpatients and associations with anxiety.European journal of obstetrics, gynecology, and reproductive biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Vrutangkumar V ShahDepartment of Neurology, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0002-8626-1089
Barbara H BrumbachOHSU-PSU School of Public Health, Oregon Health & Science University, Portland, OR 97201, USA.
Sean PearsonAPDM Wearable Technologies-a Clario Company, Portland, OR 97201, USA.
Paul VasilyevAPDM Wearable Technologies-a Clario Company, Portland, OR 97201, USA.
Edward KingAPDM Wearable Technologies-a Clario Company, Portland, OR 97201, USA.
Patricia Carlson-KuhtaDepartment of Neurology, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0002-5794-4155
Martina ManciniDepartment of Neurology, Oregon Health & Science University, Portland, OR 97239, USA.
Fay B HorakDepartment of Neurology, Oregon Health & Science University, Portland, OR 97239, USA.ORCID 0000-0001-7704-5459
Kristen SowalskyAPDM Wearable Technologies-a Clario Company, Portland, OR 97201, USA.
James McNamesAPDM Wearable Technologies-a Clario Company, Portland, OR 97201, USA.ORCID 0000-0001-8091-3560
Mahmoud El-GoharyAPDM Wearable Technologies-a Clario Company, Portland, OR 97201, USA.ORCID 0000-0002-2678-8823
Oregon Health & Science University · USPortland State University · US

Funding

APDM Wearable Technologies - a Clario Company N/A
6 · The paper itself

Abstract

Physical activity and sleep monitoring in daily life provide vital information to track health status and physical fitness. The aim of this study was to establish concurrent validity for the new Opal Actigraphy solution in relation to the widely used ActiGraph GT9X for measuring physical activity from accelerometry epic counts (sedentary to vigorous levels) and sleep periods in daily life. Twenty participants (age 56 + 22 years) wore two wearable devices on each wrist for 7 days and nights, recording 3-D accelerations at 30 Hz. Bland-Altman plots and intraclass correlation coefficients (ICCs) assessed validity (agreement) and test-retest reliability between ActiGraph and Opal Actigraphy sleep durations and activity levels, as well as between the two different versions of the ActiGraph. ICCs showed excellent reliability for physical activity measures and moderate-to-excellent reliability for sleep measures between Opal versus Actigraph GT9X and between GT3X versus GT9X. Bland-Altman plots and mean absolute percentage error (MAPE) also show a comparable performance (within 10%) between Opal and ActiGraph and between the two ActiGraph monitors across activity and sleep measures. In conclusion, physical activity and sleep measures using Opal Actigraphy demonstrate performance comparable to that of ActiGraph, supporting concurrent validation. Opal Actigraphy can be used to quantify activity and monitor sleep patterns in research and clinical studies.

Indexed as

ActigraphySleepAccelerometryAdultAgedHumansMiddle AgedPolysomnographyReproducibility of ResultsActiGraphactivitydaily lifeIMUssleepvaliditywearable sensors

Identifiers

PMID36850896
PMCPMC10003936
OpenAlexW4321375411

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read10
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.